UK approves Novo Nordisk's Wegovy pill
Novo Nordisk's fast-growing Wegovy pill has been approved in the UK for weight loss, its first European market.
Newsletters and Deep Dive digital magazine
Novo Nordisk's fast-growing Wegovy pill has been approved in the UK for weight loss, its first European market.
Eli Lilly has recruited basketball legend Shaquille O'Neal to promote a sleep apnoea awareness campaign and make the case for treatment with Zepbound.
Lilly's Ebglyss has claimed an FDA approval for less-frequent maintenance dosing that could give it an edge over market leader Dupixent.
The EMA has started its review of Bayer's asundexian for secondary stroke prevention, keeping it ahead of a rival drug from BMS and J&J.
GSK is preparing for its biggest acquisition in more than 10 years, agreeing to buy cancer drug developer Nuvalent for $10.6 billion.
Editor's Picks
Newsletters and Deep Dive
digital magazine